Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2015 | Standardized extract of Wedelia chinensis for prostate cancer treatment by targeting intrinsic survival pathways and immunomodulation | Tsai, CH; Tzeng, SF; Hsieh, SC; Lin, CY; Tsai, CJ; Yang, YC; Hsiao, JH; Tsai, MH; Lee, MT; Hsiao, PW | Phytomedicine 22(3): 406-414 | | | |
2013 | Therapeutic effects of standardized Wedelia chinensis extract on prostate cancer in vivo | Hsiao, PW; Tsai, CH; Yang, YC; Lee, MT | | | | |
2009 | VKORC1 haplotypes in five East-Asian populations and Indians. | Lee, MT; Chen, CH; Chuang, HP; Lu, LS; Chou, CH; Chen, YT; Liu, CY; Wen, MS; Lu, JJ; Chang, CF; Wu, JY; Chen, YT | Pharmacogenomics 10(10), 1609-16 | | | |
2010 | Warfarin Pharmacogenetics: A single VKORC1 polymorphism is predictive of dose across three racial groups | Limdi, NA; Wadelius, M; Cavallari, L; Eriksson, N; Crawford, DC; Lee, MT; Chen, CH; Motsinger-Reif, A; Sagreiya, H; Liu, N; Wu, AH; Gage, BF; Jorgensen, A; Pirmohamed, M; Shin, JG; Suarez-Kurtz, G; Kimmel, SE; Johnson, JA; Klein, TE; Wagner, MJ; International Warfarin Pharmacogenetics Consortium | BLOOD 115(18), 3827-3834 | | | |